All News

Today’s pharmacy hero is Diane Berkley, CPhT. In addition to working full time at a local hospital during the day, Berkley also works part-time at a community pharmacy.

The FDA has issued a statement regarding action to help increase the supply of ventilators, ventilator tubing connectors, and ventilator accessories during the COVID-19 pandemic.

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

More than 60 front-end, nonprescription products are currently available for purchase at drive-thru windows.

New information from the IQVIA “Global Medicine Spending and Usage Trends” report highlights the expected growth of specialty pharmacy spending by 2024.

The FDA has issued a complete response letter for the supplemental New Drug Application of the investigational medicine empagliflozin 2.5 mg as an adjunct to insulin for adults with type 1 diabetes.

A statistical analysis predicts that more than 70,000 heart attacks, strokes, and other adverse cardiovascular events could be prevented each year in the United States through the use of a highly purified fish oil therapy.

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct but have not spread to other tissues in the breast.

The researchers noted that it is still important for people to cover their eyes, hands, and mouth to avoid virus particles spread from another person.

Which pharmacist won the Nobel Prize in 2005 for proving that Helicobacter pylori causes stomach ulcers and could therefore be treated with antibiotics?

More than 1800 members registered for the town hall-style meeting, during which Rep. Buddy Carter (R-GA), a pharmacist and congressman, briefed attendees about emergency relief efforts currently in development by policymakers, efforts to address pharmacy direct and indirect remuneration (DIR) fees, and other key issues.

According to reporting by NPR, the decision may be in response to backlash from the health care community

Recent estimates indicate that less than 10% of patients who are at risk for acquiring HIV are prescribed PrEP.

One of the primary means of performing billable services is through ‘incident-to’ billing.

For specialty pharmacies, contingency plans for COVID-19 are not as simple as moving a workforce to their remote access solutions.

Today we're thanking a pharmacist who has spent over 30 years caring for his community in New Jersey.

Ozanimod demonstrated acceptable safety and tolerability in the phase 3 SUNBEAM and RADIANCE part B trials.

New research has examined the details surrounding the signaling molecule interleukin-2, which could lead to more targeted therapies for diseases such as cancer.

Ed Cohen, PharmD, FAPhA, executive vice president of pharmacy advocacy for the publication, was recognized with the prestigious Individual Advocate of the Year award.

Guidelines recommend that Ashkenazi Jewish women discuss genetic testing with physicians, but other women with breast cancer are less likely to receive a recommendation of testing.

The research showed that the preventive effect of eptinezumab-jjmr was statistically significant versus placebo as early as day 1 and maintained throughout 3 months post-infusion.

CVS Health said it has implemented new protocols to continue to combat the pandemic and to protect the health of their employees.

A study published in Clinical Cancer Research has shown that using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC) can predict tumor sensitivity to 3 systematic cancer therapies by using artificial intelligence (AI).

These professional organizations are aware that some medications are being prophylactically prescribed as potential treatments for COVID-19.

Ben Harding, a P4 student, discusses the scenario of being a pharmacy student during the COVID-19 pandemic.

The EUA designation allows the test to be used to detect SARS-CoV-2, the virus that causes COVID-19, for the duration of the continuing pandemic.

While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.

Today, we’re celebrating Jennifer Cardona, PharmD, who works at an independent pharmacy in Puerto Rico.

Following a 7.5% increase in melanoma-related deaths among white Americans between 1986 and 2013, researchers have now found a nearly 18% decline over the following 3 years.

The FDA released a statement on taking action to increase US supplies to support the response to the coronavirus disease 2019 by providing instructions to manufacturers importing personal protective equipment and other devices.